Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New AI System Can Diagnose and Classify Intracranial Hemorrhage

By HospiMedica International staff writers
Posted on 23 Jan 2019
Researchers from the Massachusetts General Hospital (Boston, MA, USA) have developed an artificial intelligence (AI) system that can quickly diagnose and classify brain hemorrhages, as well as provide the basis of its decisions from relatively small image datasets. More...
The system could help hospital emergency departments in evaluating patients with symptoms of a potentially life-threatening stroke, allowing rapid application of the correct treatment.

The researchers trained the system with 904 head CT scans, each consisting of around 40 individual images, that were labeled by neuroradiologists as to whether they depicted one of five hemorrhage subtypes, based on the location within the brain, or no hemorrhage. The team improved the accuracy of the deep-learning system by building in steps mimicking the way radiologists analyze images. These included adjusting factors such as contrast and brightness to reveal subtle differences not immediately apparent and scrolling through adjacent CT scan slices to determine whether or not something that appears on a single image reflects a real problem or is a meaningless artifact.

After the model system was created, the investigators tested it on two separate sets of CT scans – a retrospective set taken before the system was developed, consisting of 100 scans with and 100 without intracranial hemorrhage, and a prospective set of 79 scans with and 117 without hemorrhage, taken after the model was created. In its analysis of the retrospective set, the model system was as accurate in detecting and classifying intracranial hemorrhages as the radiologists that had reviewed the scans had been. In its analysis of the prospective set, the system proved to be even better than non-expert human readers.

To solve the “black box” problem, or the inability of systems to explain how they arrived at a decision, the team had the system review and save the images from the training dataset that most clearly represented the classic features of each of the five hemorrhage subtypes. Using this atlas of distinguishing features, the system is able to display a group of images similar to those of the CT scan being analyzed in order to explain the basis of its decisions.

“Rapid recognition of intracranial hemorrhage, leading to prompt appropriate treatment of patients with acute stroke symptoms, can prevent or mitigate major disability or death,” said co-author Michael Lev, MD, MGH Radiology. “Many facilities do not have access to specially trained neuroradiologists – especially at night or over weekends – which can require non-expert providers to determine whether or not a hemorrhage is the cause of a patient’s symptoms. The availability of a reliable, ‘virtual second opinion’ – trained by neuroradiologists – could make those providers more efficient and confident and help ensure that patients get the right treatment.”

“In addition to providing that much needed virtual second opinion, this system also could be deployed directly onto scanners, alerting the care team to the presence of a hemorrhage and triggering appropriate further testing before the patient is even off the scanner,” added co-author Shahein Tajmir, MD, MGH Radiology. “The next step will be to deploy the system into clinical areas and further validate its performance with many more cases. We are currently building a platform to allow for the widespread application of such tools throughout the department. Once we have this running in the clinical setting, we can evaluate its impact on turnaround time, clinical accuracy and the time to diagnosis.”

Related Links:
Massachusetts General Hospital

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.